companydirectorylist.com  Global Business Directories and Company Directories
Search Business,Company,Industry :


Country Lists
USA Company Directories
Canada Business Lists
Australia Business Directories
France Company Lists
Italy Company Lists
Spain Company Directories
Switzerland Business Lists
Austria Company Directories
Belgium Business Directories
Hong Kong Company Lists
China Business Lists
Taiwan Company Lists
United Arab Emirates Company Directories


Industry Catalogs
USA Industry Directories














  • Obesity and overweight - World Health Organization (WHO)
    Obesity and overweight fact sheet from WHO providing key facts and information on causes, health consequences, double burden of disease, prevention, WHO response
  • Obesity - World Health Organization (WHO)
    Overweight and obesity are defined as abnormal or excessive fat accumulation that presents a risk to health A body mass index (BMI) over 25 is considered overweight, and over 30 is obese In 2019, an estimated 5 million noncommunicable disease (NCD) deaths were caused by higher-than-optimal BMI
  • Obesity - World Health Organization (WHO)
    Obesity has reached epidemic proportions globally, with at least 2 8 million people dying each year as a result of being overweight or obese
  • 肥胖和超重 - World Health Organization (WHO)
    概述 超重是脂肪沉积过多的状况。 肥胖是由可能导致健康损害的脂肪过量沉积所定义的一种慢性复杂疾病。肥胖会增加患2型糖尿病和心脏病的风险,会影响到骨骼健康和生殖系统,并增加罹患某些癌症的风险。肥胖对生活质量造成影响,如睡眠或活动。 通过测量人的体重和身高,并计算体重指数
  • Obesidad y sobrepeso - World Health Organization (WHO)
    El sobrepeso y la obesidad se definen como una acumulación anormal o excesiva de grasa que puede ser perjudicial para la salud
  • The challenge of obesity - World Health Organization (WHO)
    Obesity, the challenge ofKey facts Overweight and obesity are among the leading causes of disability and death in the WHO European Region; recent estimates suggest that they cause more than 1 2 million deaths across the Region every year Overweight and obesity are the fourth most common risk factor for noncommunicable diseases (NCDs) in the Region, after high blood pressure, dietary risks and
  • WHO issues global guideline on the use of GLP-1 medicines in treating . . .
    To address the growing global health challenge of obesity, which affects more than 1 billion people, WHO has released its first guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies for treating obesity as a chronic, relapsing disease
  • Principaux repères sur lobésité et le surpoids
    Le surpoids est un état caractérisé par un dépôt excessif de tissu adipeux L’obésité est une maladie chronique complexe qui se définit par un dépôt excessif de tissu adipeux pouvant nuire à la santé




Business Directories,Company Directories
Business Directories,Company Directories copyright ©2005-2012 
disclaimer